Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Immunovant Q2 EPS $(0.41) Down From $(0.35) YoY

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.41) per share. This is a 17.14 percent decrease over losses of $(0.35) per share from the same period last year.
byBenzinga Newsdesk
November 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.41) per share. This is a 17.14 percent decrease over losses of $(0.35) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

S&P 500 Settles Lower But Records Weekly Gain, Market Volatility Decreases

By Lisa Levin
April 17, 5:50 AM
The S&P 500 closed lower on Friday following the release of mixed economic reports. All three major stock indices, however, recorded gains last week. Retail sales in the U.S. dropped 1% month-over-month in March versus a revised 0.2% decline in February. The University of Michigan consumer sentiment rose to 63.5 in April from 62 in the prior month.

BAC